Pol S - Search Results

1

Liver fibrosis and all-cause mortality in chronic HCV-infected diabetic patients: A paradoxical association? (ANRS CO22 HEPATHER).

Barré T, Ramier C, Di Beo V, Carrat F, Fontaine H, Marcellin F, Carrieri P, Pol S, Protopopescu C; ANRS/AFEF Hepather study group. Barré T, et al. Among authors: pol s. Liver Int. 2021 Jul;41(7):1694-1698. doi: 10.1111/liv.14949. Epub 2021 May 28. Liver Int. 2021. PMID: 33993651 Free article. No abstract available.

2

Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients.

Pol S, Fontaine H, Carnot F, Zylberberg H, Berthelot P, Bréchot C, Nalpas B. Pol S, et al. J Hepatol. 1998 Jul;29(1):12-9. doi: 10.1016/s0168-8278(98)80173-6. J Hepatol. 1998. PMID: 9696487

3

[Murderous impulses in two patients with chronic hepatitis C treated with interferon alpha].

Rifflet H, Pol S, Vuillemin E, Oberti F, Duverger P, Lainé P, Garre JB, Calès P. Rifflet H, et al. Among authors: pol s. Gastroenterol Clin Biol. 1998 Jan;22(1):105-6. Gastroenterol Clin Biol. 1998. PMID: 9762179 French. No abstract available.

4

Triggering of acute alcoholic hepatitis by alpha-interferon therapy.

Zylberberg H, Fontaine H, Thépot V, Nalpas B, Bréchot C, Pol S. Zylberberg H, et al. Among authors: pol s. J Hepatol. 1999 Apr;30(4):722-5. doi: 10.1016/s0168-8278(99)80205-0. J Hepatol. 1999. PMID: 10207816

5

[Treatment of chronic hepatitis C: interferon alpha-2b alone or in combination with ribavirin].

Fontaine H, Pol S. Fontaine H, et al. Among authors: pol s. Gastroenterol Clin Biol. 1999 Apr;23(4):541-4. Gastroenterol Clin Biol. 1999. PMID: 10416124 Free article. French. No abstract available.

6

A randomized trial of ribavirin and interferon-alpha vs. interferon-alpha alone in patients with chronic hepatitis C who were non-responders to a previous treatment. Multicenter Study Group under the coordination of the Necker Hospital, Paris, France.

Pol S, Couzigou P, Bourlière M, Abergel A, Combis JM, Larrey D, Tran A, Moussalli J, Poupon R, Berthelot P, Bréchot C. Pol S, et al. J Hepatol. 1999 Jul;31(1):1-7. doi: 10.1016/s0168-8278(99)80157-3. J Hepatol. 1999. PMID: 10424277 Clinical Trial.

7

Treatment of chronic hepatitis C in special groups.

Pol S, Zylberberg H, Fontaine H, Bréchot C. Pol S, et al. J Hepatol. 1999;31 Suppl 1:205-9. J Hepatol. 1999. PMID: 10622589 Review.

8

Combination of ribavirin and interferon-alfa surpasses high doses of interferon-alfa alone in patients with genotype-1b-related chronic hepatitis C.

Pol S, Nalpas B, Bourlière M, Couzigou P, Tran A, Abergel A, Zarski JP, Berthelot P, Bréchot C. Pol S, et al. Hepatology. 2000 Jun;31(6):1338-44. doi: 10.1053/jhep.2000.8089. Hepatology. 2000. PMID: 10827161 Clinical Trial.

9

HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients.

Fontaine H, Thiers V, Chrétien Y, Zylberberg H, Poupon RE, Bréchot C, Legendre C, Kreis H, Pol S. Fontaine H, et al. Among authors: pol s. Transplantation. 2000 May 27;69(10):2090-4. doi: 10.1097/00007890-200005270-00020. Transplantation. 2000. PMID: 10852602

10

Dilated bile duct in patients receiving narcotic substitution: an early report.

Zylberberg H, Fontaine H, Corréas JM, Carnot F, Bréchot C, Pol S. Zylberberg H, et al. Among authors: pol s. J Clin Gastroenterol. 2000 Sep;31(2):159-61. doi: 10.1097/00004836-200009000-00015. J Clin Gastroenterol. 2000. PMID: 10993435

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

936 results

Search Page

Filters